{'fraction_non_alphanumeric': 0.03589315525876461, 'fraction_numerical': 0.02003338898163606, 'mean_word_length': 4.764423076923077, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Unilateral Acute Idiopathic Maculopathy following Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) Infection.

AIM
To report a case of unilateral acute idiopathic maculopathy (UAIM) following SARS-CoV-2 virus infection.


CASE DESCRIPTION
A 44-year-old male patient, infected with SARS-CoV-2 virus previously, presented to the retina department with complaints of sudden blurring of vision in right eye. His presenting visual acuity in right eye was 20/30, N8. Fundus showed an irregular area of yellowish-white subretinal lesion at the macula involving the fovea with reddish-brown pigment clumps. Retinal imaging findings were consistent with the diagnosis of UAIM. No treatment was given.


RESULTS
The imaging findings showed improvement at day 7 post-presentation with improvement in vision to 20/20, N6. At final visit (5-week post presentation), visual acuity was maintained at 20/20, N6 and there was no recurrence of findings.


EXPERT OPINION
Unilateral acute idiopathic maculopathy might be associated with SARS-CoV-2 virus infection.


CONCLUSION
Infection with SARS-CoV-2 virus might be associated with UAIM. Such an association has not yet been described in the literature.